Wojciech Jurczak
ASCO/EHA/ICML 2021 - Wojciech Jurczak Wojciech Jur
ASCO/EHA/ICML 2021 - Wojciech Jurczak Wojciech Jur
ASCO/EHA/ICML 2021 - Matthew Davids Matthew Davids
ASCO/EHA/ICML 2021 - Alvaro Alencar Alvaro Alenca
Zanubrutinib in relapsed/refractory marginal zon
Mantle cell lymphoma: improving outcomes in diff
Extending anti-PD-1–based options in the setting
Successful inhibition of PI3K, BTK, BCL2 and oth
Waldenström’s macroglobulinemia: outcome optimiz
CLL/SLL: current perspectives across a range of
Preface – ASCO/EHA/ICML 2021 Véronique